Cross Over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Clinical trial NCT01105208 · COMPLETED

Trial details

NCT number: NCT01105208
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anti-Infective Agents

Start date: 2010-03-01
Primary completion: 2010-03-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.